Biotech Growth Investors & VC Firms
747 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.
Horizon Technology Finance
FarmingtonGrowth–Late Stage$3M – $50M
2 people
Infinity Group
Tel AvivGrowth$1M – $10M
2 people
KittyHawk Ventures
Silicon ValleySeed–Late Stage$250K – $15M
2 people
Klein & Partners AG
ZugGrowth–Late Stage$550K – $5.5M
2 people
Lewis & Clark AgriFood
St. LouisSeries A–Late Stage$2M – $10M
2 people
London & Scottish Investment Partners
EdinburghSeed–Growth$130K – $320K
2 people
Montis Capital
WarsawSeries A–Growth$1.6M – $5.5M
2 people
JourneyOne Ventures
BoulderPre-Seed–Growth
1 person
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
1 person
ACORN BIOVENTURES
New YorkSeed–Late Stage
4 people
Elevat3 Capital
VallettaSeed–Growth$5M – $20M
Innventure
Pre-Seed–Growth
Strattech Partners, LLC
WayneSeed–Growth
2 people
Waterpoint Lane
MiamiSeed–Late Stage
2 people
Lichen Ventures
BaltimoreSeed–Late Stage$200K
1 person
Boston Millennia Partners
BostonSeed–Late Stage$3M – $5M
7 people
First Venture
StockholmSeed–Growth
4 people
Trinity Innovation Bioventure Singapore
SingaporeSeed–Late Stage
3 people
Fir Capital
Nova LimaSeed–Growth$100K – $5M
1 person
Northern Greece Investment Fund (NGIF)
ThessalonikiGrowth$1.6M – $3.2M
1 person
Majuven
SingaporeSeed–Late Stage
4 people
South China Venture Capital
ShenzhenSeed–Late Stage
4 people
Reverent Partners
SeoulSeries A–Late Stage
AgriBoom Ventures
Pre-Seed–Late Stage$10K – $4.4M
1 person
Related lists
Growth Investors & VC Firms (4757)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Growth Investors & VC Firms (1213)Enterprise Software Growth Investors & VC Firms (1186)SaaS Growth Investors & VC Firms (1173)Growth Investors & VC Firms in Europe (1149)
Data sourced from public filings and firms' own websites — see our methodology.








